Last reviewed · How we verify
A Phase III Trial of External Beam of Radiotherapy +/- Total Androgen Suppression for High Risk Clinically Organ-Confined Prostate Cancer
This clinical study was to determine if the use of 6 months of total androgen suppression (hormonal therapy) when added to radiation therapy for localized-high risk prostate cancer would improve overall survival.
Details
| Lead sponsor | Dana-Farber Cancer Institute |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 206 |
| Start date | 1995-09 |
| Completion | 2015-02 |
Conditions
- Prostate Cancer
Interventions
- Flutamide (Eulexin) and Lupron or Zoladex
- External Beam Radiotherapy
Primary outcomes
- To determine if the 2 year freedom from PSA failure is increased in patients receiving total androgen suppression and radiation therapy compared to those patients receiving radiation therapy alone. — Years
Countries
United States